Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0461 Transporter Info | ||||
Gene Name | SLC6A9 | ||||
Transporter Name | Sodium- and chloride-dependent glycine transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | ORG-25935 Drug Info | ||||
Xenobiotic Type | Drug in Phase 2 Trial | ||||
MOA | Inhibition | ||||
PubChem CID | 11717074 | ||||
Docking Score | -8.34 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C21H25NO3 | ||||
Molecular Weight | 339.4 | ||||
Canonical SMILES |
CN(C[C@H]1CCC2=C([C@H]1C3=CC=CC=C3)C=CC(=C2)OC)CC(=O)O
|
||||
InChI |
InChI=1S/C21H25NO3/c1-22(14-20(23)24)13-17-9-8-16-12-18(25-2)10-11-19(16)21(17)15-6-4-3-5-7-15/h3-7,10-12,17,21H,8-9,13-14H2,1-2H3,(H,23,24)/t17-,21+/m1/s1
|
||||
InChIKey | UEBBYLJZCHTLEG-UTKZUKDTSA-N | ||||
Pharmaceutical Properties | Xlogp | 1.6 | Rotatable Bond Count | 6 | |
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | ||
Xenobiotic Name | PF-3463275 Drug Info | ||||
Xenobiotic Type | Drug in Phase 2 Trial | ||||
MOA | Inhibition | ||||
PubChem CID | 44156901 | ||||
Docking Score | -8.273 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C19H22ClFN4O | ||||
Molecular Weight | 376.9 | ||||
Canonical SMILES |
CN1C[C@@H]2[C@H](C1)C2CN(CC3=CC(=C(C=C3)F)Cl)C(=O)C4=CN(C=N4)C
|
||||
InChI |
InChI=1S/C19H22ClFN4O/c1-23-7-13-14(8-23)15(13)9-25(19(26)18-10-24(2)11-22-18)6-12-3-4-17(21)16(20)5-12/h3-5,10-11,13-15H,6-9H2,1-2H3/t13-,14+,15?
|
||||
InChIKey | KYLOBHXXQOZRKK-YIONKMFJSA-N | ||||
Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 5 | |
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.